Exploring the potential of polypeptide–polypeptoide hybrid nanogels for mucosal delivery-Reference-Cited by-同舟云学术

Exploring the potential of polypeptide–polypeptoide hybrid nanogels for mucosal delivery

Published:2022 Issue:42 Volume:13 Page:6054-6060
ISSN:1759-9954
Container-title:Polymer Chemistry
language:en
Short-container-title:Polym. Chem.

Author:

Xu Tao¹²,Skoulas Dimitrios³^ORCID,Ding Dawei²,Cryan Sally-Ann¹⁴⁵^ORCID,Heise Andreas³⁴⁵^ORCID

Affiliation:

1. School of Pharmacy and Biomolecular Sciences and Tissue Engineering Research Group, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland

2. College of Pharmaceutical Sciences, Soochow University, 199 Ren'ai Road, Suzhou 215123, China

3. Department of Chemistry, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland

4. Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CURAM), RCSI, Dublin 2, Ireland

5. AMBER, The SFI Advanced Materials and Bioengineering Research Centre, RCSI, Dublin 2, Ireland

Abstract

By chain extension of polysarcosine with phenylalanine and cystine, nanogels are formed. The nanogels facilitate the transport of dyes across an artificial mucus coated membrane and their release by reductive bond cleavage.

Funder

Priority Academic Program Development of Jiangsu Higher Education Institutions

H2020 Marie Skłodowska-Curie Actions

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Polymers and Plastics,Biochemistry,Bioengineering

Link

http://pubs.rsc.org/en/content/articlepdf/2022/PY/D2PY01126C

Reference57 articles.

1. Nanomedicine: Principles, Properties, and Regulatory Issues

2. Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures